These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 7031039)

  • 1. Mesoridazine -- a pharmacodynamic and pharmacokinetic profile.
    Gershon S; Sakalis G; Bowers PA
    J Clin Psychiatry; 1981 Dec; 42(12):463-9. PubMed ID: 7031039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesoridazine and thioridazine: clinical effects and blood levels in refractory schizophrenics.
    Vital-Herne J; Gerbino L; Kay SR; Katz IR; Opler LA
    J Clin Psychiatry; 1986 Jul; 47(7):375-9. PubMed ID: 2873133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study of two antipsychotic drugs in a state hospital.
    Palestine ML
    Dis Nerv Syst; 1972 Jun; 33(6):395-402. PubMed ID: 4668959
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mesoridazine (TPS 23 Sandoz) in acute psychotic states].
    Jost F; Zmorski T
    Schweiz Arch Neurol Neurochir Psychiatr; 1973; 112(1):131-42. PubMed ID: 4570413
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment with mesoridazine and thioridazine in chronic schizophrenia: I. Assessment of clinical and electrophysiologic responses in refractory hallucinating schizophrenics.
    Gardos G; Tecce JJ; Hartmann E; Bowers P; Cole JO
    Compr Psychiatry; 1978; 19(6):517-25. PubMed ID: 720036
    [No Abstract]   [Full Text] [Related]  

  • 6. Absorption and excretion of thioridazine and mesoridazine in man.
    Charalampous KD; Johnson PC; Estevez V
    Dis Nerv Syst; 1974 Nov; 35(11):494-6. PubMed ID: 17896456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of a possible new metabolite of thioridazine and mesoridazine from human plasma.
    Dinovo EC; Gottschalk LA; Noble EP; Biener R
    Res Commun Chem Pathol Pharmacol; 1974 Mar; 7(3):489-96. PubMed ID: 4824823
    [No Abstract]   [Full Text] [Related]  

  • 8. Mesoridazine in neuroleptic-resistant psychoses.
    Osser DN; Albert LG; Figueiredo S; O'Connor H; Barden Y; Carmichael WG
    J Clin Psychopharmacol; 1991 Oct; 11(5):328-30. PubMed ID: 1684976
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on thioridazine and mesoridazine metabolism. I. Protein binding.
    Forrest IS; Green DE; Blum A; Serra MT; Loeffler KO
    Commun Psychopharmacol; 1979; 3(5):319-22. PubMed ID: 548210
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of the effects of thioridazine and mesoridazine on the QT interval in healthy adults after single oral doses.
    Salih IS; Thanacoody RH; McKay GA; Thomas SH
    Clin Pharmacol Ther; 2007 Nov; 82(5):548-54. PubMed ID: 17410120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serentil for chronic brain syndrome.
    Med Lett Drugs Ther; 1975 Aug; 17(16):68. PubMed ID: 1152819
    [No Abstract]   [Full Text] [Related]  

  • 12. A double-blind comparison of mesoridazine and chlorpromazine in chronic schizophrenics.
    Freeman H
    Dis Nerv Syst; 1973; 34(6):289-93. PubMed ID: 4782285
    [No Abstract]   [Full Text] [Related]  

  • 13. GLC analysis of thioridazine, mesoridazine, and their metabolites.
    Dinovo EC; Gottschalk LA; Nandi BR; Geddes PG
    J Pharm Sci; 1976 May; 65(5):667-9. PubMed ID: 932933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Partitioning of thioridazine and mesoridazine in human blood fractions.
    Dinovo EC; Pollak H; Gottschalk LA
    Methods Find Exp Clin Pharmacol; 1984 Mar; 6(3):143-6. PubMed ID: 6748818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac conduction and rhythm disturbances following suicidal ingestion of mesoridazine.
    Niemann JT; Stapczynski JS; Rothstein RJ; Laks MM
    Ann Emerg Med; 1981 Nov; 10(11):585-8. PubMed ID: 7316263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of mesoridazine in geriatrics.
    Goldstein SE
    Curr Ther Res Clin Exp; 1974 Apr; 16(4):316-23. PubMed ID: 4208348
    [No Abstract]   [Full Text] [Related]  

  • 17. Thioridazine (Mellaril) and mesoridazine (Serentil): prolongation of the QTc interval.
    Dallaire S
    CMAJ; 2001 Jan; 164(1):91, 95. PubMed ID: 11202679
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma levels of mesoridazine and its metabolites and clinical response in acute schizophrenia after a single intramuscular drug dose.
    Gottschalk LA; Dinovo E; Bierner R
    Psychopharmacol Bull; 1975 Oct; 11(4):33-4. PubMed ID: 812135
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment with mesoridazine and thioridazine in chronic schizophrenia: II. Potential predictors of drug response.
    Gardos G; Tecce JJ; Hartmann E; Bowers P; Cole JO
    Compr Psychiatry; 1978; 19(6):527-32. PubMed ID: 720037
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma and red cell levels of thioridazine and clinical response in schizophrenia.
    Smith RC; Baumgartner R; Ravichandran GK; Shvartsburd A; Schoolar JC; Allen P; Johnson R
    Psychiatry Res; 1984 Aug; 12(4):287-96. PubMed ID: 6594712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.